Improving Detection and Diagnosis of Alzheimer’s Disease and Related Dementias

Improving Detection and Diagnosis of Alzheimer’s Disease and Related Dementia is a call to action to the worldwide health care system in the fight to stop dementias by 2025. Click below to read the first CEOi white paper submitted to the World Health Organization and co-authored by UsAgainstAlzheimer's Co-Founder and Chair George Vradenburg, Acting President Drew Holzapfel, and Cassie Dormond.

Read More
Brain Health

The Brain Health Partnership

Our goal is to improve health outcomes for people living with or at risk of Alzheimer’s and related dementias. To accomplish this, we are embarking on a Brain Health Partnership initiative, with others, to make a check-up from the neck up a routine aspect of clinical care, to encourage people to make lifestyle choices that reduce their risk, to accelerate the widespread availability of treatments and medicines, and to reduce health care costs.

Learn More

How We are Accelerating a Cure

We’re done waiting. Help us take action and accelerate an Alzheimer’s cure for all. Join us!

Watch Video
Disparity

The Changing Face of Alzheimer’s

Alzheimer’s disproportionately affects Latinos, African Americans, and women. It’s time to build a more inclusive Alzheimer’s movement.

Learn More
Caregiving

Millennials and Dementia Caregiving

About half of millennial dementia caregivers stated that caregiving interfered with work, and 33% reported severe interference with work.

Download Now

The Role of Tau: What Do We Know?

For 30 years, Professor Claude Wischik, co-founder of TauRx, has explored the role of tau in the development of Alzheimer’s and other dementias.

Listen Now

Global CEO Initiative on Alzheimer's Disease

Brain Health Partnership

Our Theory of Change

Education

Millennials and Dementia Caregiving

Alzheimer’s Talks

  • A Letter from Our Chairman

    Anyone who has dealt with Alzheimer's knows the terrible toll it takes on patients and their families. I watched in horror as my wife’s brilliant, vibrant, extraordinary mother disappeared into the disease in the early 1990s. Alzheimer’s is a cancer-sized problem, and it demands a cancer-sized solution.

  • A Letter from Our Chairman

    NIH research funding for Alzheimer’s is increasing, but not fast enough to address the crisis at hand. While other disease states have decreasing death rates, the Alzheimer’s death rate has increased at a staggering pace. We need increases in research funding to keep up.

  • A Letter from Our Chairman

    Every 65 seconds another family learns a loved one has been diagnosed with Alzheimer’s. I’ve had enough. Join me and demand more funding for Alzheimer’s. Together, we will find a cure. Sincerely, George Vradenburg.

We Are Committed to Stopping Alzheimer's by 2020.

  • Blog Post
    Thumbnail

    Ending the Stigma

    This past year my husband, Dr. Don Wendorf, and I have had the privilege of serving as Senior Editors for ClergyAgainstAlzheimer’s upcoming book, Dementia-friendly Worship: A Multifaith Handbook for Chaplains,

    Read more
  • WATCH NOW: UsAgainstAlzheimer's 2018 National Alzheimer's Summit Live Stream

    Below you'll find the full suite of sessions from the 2018 National Alzheimer's Summit. That National Alzheimer's Summit took place September 24th- 26th in Washington D.C. Panelists and attendees from

    Read more
  • Press Release
    Thumbnail
    September 06, 2018

    UsAgainstAlzheimer’s Welcomes Eli Lilly Report of Positive Phase III Trial

    UsAgainstAlzheimer’s Chairman George Vradenburg issued the following statement regarding the report by Eli Lilly and Company and Avid Radiopharmaceuticals (a subsidiary of Eli Lilly) that flortaucipir, a Positron Emission Tomography imaging

    Read more

Dementia Caregiver's Report

Millenials and Dementia

This issue brief explores millennial caregiving in the United States with the goal of enhancing our understanding of the experiences and challenges of young adults providing care for a family member or friend living with Alzheimer’s disease or other dementias.